UNIGE document Scientific Article
previous document  unige:89801  next document
add to browser collection
Title

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

Authors
Serratrice, Christine
Carballo, Sebastian
Published in Core Evidence. 2016, vol. 11, p. 37-47
Abstract Gaucher disease is the first lysosomal disease to benefit from enzyme replacement therapy, thus serving as model for numerous other lysosomal diseases. Alglucerase was the first glucocerebrosidase purified from placental extracts, and this was then replaced by imiglucerase - a Chinese hamster ovary cell-derived glucocerebrosidase.
Identifiers
PMID: 27790078
Full text
Article (Published version) (154 Kb) - public document Free access
Structures
Research group Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) (585)
Citation
(ISO format)
SERRATRICE, Christine et al. Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy. In: Core Evidence, 2016, vol. 11, p. 37-47. https://archive-ouverte.unige.ch/unige:89801

63 hits

21 downloads

Update

Deposited on : 2016-12-02

Export document
Format :
Citation style :